PERE’s 2024 Life Sciences report takes a closer look at a sector ripe for recovery
Despite lackluster fundraising and transaction totals, experts agree demand drivers remain for life sciences companies to continue expanding, led by aging population and AI integration. Overbuilt areas and emerging markets alike are set to rebound as absorption picks up in the years ahead.
INSIDE PERE'S LIFE SCIENCES REPORT
The future is bright for life sciences property
FURTHER COVERAGE
LATEST OFFICE SECTOR NEWS
Click here to access PERE’s in-depth special reports covering a wide array of topics, plus our digital magazines.